SSB has integrated its products into unit operations for media/buffer preparation, seed fermentation, cell cultivation and harvesting, ultra-diafiltration, membrane chromatography, and viral clearance for biopharmaceutical development and manufacturing. Combining SSB’s technology with G-Con’s modular, scalable, and flexible pod platform will provide the biopharmaceutical manufacturing industry with an unparalleled set of cost-effective, plug and play tools for next-generation manufacturing facilities.
Maik Jornitz, SSB’s senior vice president of marketing for bioprocess solutions, stated, “The combined product portfolio will fundamentally change the way biopharmaceutical manufacturing processes will be designed and configured. Our integrated solutions unit will implement G-Con’s platform of modular clean-room systems into their designs. In addition, our teams will benefit from G-Con’s engineering and design expertise. Our vision is to create standardized unit operations, implemented into the self-contained G-Con modules. These modules can be used as individual process units or joined to an entire process.”
Barry Holtz, president of G-Con Manufacturing, stated, “Our common goal is to combine our complementary expertise to develop revolutionary solutions for the next-generation of flexible, single-use manufacturing concepts. We couldn’t be more excited about having an agreement with a leader in single-use products like Sartorius Stedim Biotech.”
Effective immediately, G-Con’s modular containment units are available through SSB’s integrated solutions unit and will be rolled out globally in early 2012.
Mr. Jornitz commented, “We do not want to delay the availability of the G-Con units and therefore decided to have our integrated solutions unit utilize the containment systems and G-Con’s engineering capabilities now. The global launch through our sales organizations will follow.”
Sartorius Stedim Biotech is a provider of equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management, and lab technologies are supporting the biopharmaceutical industry worldwide to develop and produce drugs safely, timely, and cost-effectively.
Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is focused on transforming science into solutions.
Headquartered in Aubagne, France, Sartorius Stedim Biotech’s manufacturing, and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
G-Con enables developing technologies by significantly lowering the expense and complexity of manufacturing biologic materials to good manufacturing practice (GMP) standards. The G-Con pod solution is completely self-contained and simple to maintain, reducing the need for sophisticated and expansive purpose-built facilities and specialized maintenance. Moreover, G-Con pods can be custom built in a fraction of the time required for a traditional facility and at significantly less cost. G-Con maintains an integrated product team of engineers with bioprocess development, mechanical, electrical, and heating, ventilation, and air conditioning experience combined with a regulatory and quality management system that is qualified to deliver on every size of GMP project.
Related Links:
Sartorius Stedim Biotech
G-Con
